‘With Advances In Science, Treating Breast Cancer Isn't As Frightening As It Might Have Been Earlier'
Express Healthcare|November 2018

OncoStem Diagnostics has launched CanAssist-Breast,a test which can reportedly predict the likelihood of cancer returning by analysing samples of a patient’s tumour through a machine learning-based algorithm.Dr Manjiri Bakre,CEO & Founder,OncoStem Diagnostics,reveals how the test can revolutionise breast cancer treatment,help avoid chemotherapy for low-risk patients and prevent breast cancer recurrence with personalised treatment protocols, in an exclusive interview with Lakshmipriya Nair

Lakshmipriya Nair
‘With Advances In Science, Treating Breast Cancer Isn't As Frightening As It Might Have Been Earlier'

How does CanAssist breast make the diagnosis of breast cancer recurrence more accurate and affordable? CanAssist breast from OncoStem Diagnostics is a test that can spare early-stage breast cancer patients from chemotherapy by accurately predicting the risk of recurrence.

Each year about 1,50,000 women are detected with breast cancer in India. A majority (~95 per cent) of early stage (Stage 1 &2) breast cancer patients get chemotherapy to avoid cancer recurrence. Currently, there is minimal awareness about tests that predict the risk of cancer recurrence. As a result, patients with low risk of recurrence are often overtreated and consequently bear various toxic effects of chemotherapy treatment that reduces their quality of life. The benefit that early-stage patients receive from chemotherapy is usually low. Since most early-stage patients do well without chemotherapy, this makes accurate risk prediction an all-important prerequisite for effective treatment. It is therefore necessary to detect low-risk instances to avoid overtreatment in the form of chemotherapy, given its side effects and the toll it takes on the patients’ quality of life.

With all the advances in science, treating breast cancer isn’t as frightening as it might have been earlier. Today, not all women diagnosed with early stage breast cancer need to undergo chemotherapy. OncoStem’s CanAssist-Breast is designed to classify patients depending on the risk of cancer recurrence. By analysing the patient’s tumour biology, CanAssist-Breast identifies ‘low-risk’ patients who will have minimal benefit of adding chemotherapy to their treatment and ‘high-risk’ patients who will benefit the most by adding it.

Esta historia es de la edición November 2018 de Express Healthcare.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

Esta historia es de la edición November 2018 de Express Healthcare.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

MÁS HISTORIAS DE EXPRESS HEALTHCAREVer todo
Healthcare Communication In India
Express Healthcare

Healthcare Communication In India

Dr Alexander Thomas, President, Association of Healthcare Providers - India (AHPI) and Divya Alexander, Research Consultant, in a first of a series provide detailed insights on healthcare communication that explores its different aspects in an Indian context

time-read
6 minutos  |
March 2020
The growth story
Express Healthcare

The growth story

Himanshu Baid, Managing Director, Poly Medicure elucidates on how Poly Medicure has served the medical fraternity for over 22 years and owns more than 215 patents and continues to file new patents for new technologies and devices they are developing with the help of its R&D team

time-read
2 minutos  |
March 2020
Main objective of Indian Joint Registry is to help patient safety, bring stability to the market
Express Healthcare

Main objective of Indian Joint Registry is to help patient safety, bring stability to the market

In the wake of several patients suffering from the impact of faulty hip implants, it is vital that India has a national joint registry to track such patients and avoid future episodes. Richard Armstrong, Head, Health Registries, Northgate Public Services tells Viveka Roychowdhury about the response to the Indian Joint Registry

time-read
4 minutos  |
March 2020
Express Healthcare

UNDERSTANDING THE RELEVANCE OF HEALTHCARE RESEARCH

India as a nation has followed the west for decades when it comes to research-based treatments. The sun is fast setting on this methodology and there is a massive need to invest in healthcare research in the country

time-read
8 minutos  |
March 2020
I have witnessed the steady technical advances in ultrasound
Express Healthcare

I have witnessed the steady technical advances in ultrasound

Dr BS Rama Murthy, Consultant Radiologist, Srinivasa Ultrasound Scanning Centre and Chief Patron, Medical Ultrasound Society of Karnataka, Coordinator – Fetal Foundation of India, talks about the evolution of ultrasound and how foetal imaging has improved over the years, in an interaction with Express Healthcare

time-read
4 minutos  |
March 2020
Radiology has a bright future and has been at the forefront of healthcare
Express Healthcare

Radiology has a bright future and has been at the forefront of healthcare

Radiology has a major role to play when it comes to healthcare. Dr Piyush Saxena, Consultant Radiologist and Chief of MR imaging, Vishesh Hospital and Diagnostics, Indore, MP in an exclusive conversation with Express Healthcare disscuses the impact of radiology on healthcare and how newer innovations from GE Healthcare has helped improve healthcare delivery as well as patient comfort

time-read
4 minutos  |
March 2020
The Pill For India's Ailing Medical Eductaion System
Express Healthcare

The Pill For India's Ailing Medical Eductaion System

Medical education in India is mired with a host of controversies and is trudging along a rough path.

time-read
6 minutos  |
February 2020
RED INITIATIVE - Canon Medical / Erbis Engineering conducts CME programmes on CTO-PCIs in Chennai
Express Healthcare

RED INITIATIVE - Canon Medical / Erbis Engineering conducts CME programmes on CTO-PCIs in Chennai

Invites renowned Japanese cardiac interventionist, Dr Kinzo Ueda to India to share his experiences and insights with cardiologists at Apollo Hospitals and Sri Ramachandra Institute of Higher Education and Research

time-read
8 minutos  |
February 2020
Roche Diagnostics partners with SRL Dr Avinash Phadke Lab
Express Healthcare

Roche Diagnostics partners with SRL Dr Avinash Phadke Lab

Roche’s first partner for cobas pro solution is SRL Dr Avinash Phadke Lab in Mumbai. The solution promises to offer greater automation, flexibility and simplified workflow to support better clinical outcomes for patients

time-read
5 minutos  |
February 2020
Pharmacogenomics- Essential to end the era of trial and error medicine
Express Healthcare

Pharmacogenomics- Essential to end the era of trial and error medicine

Chandni Luthra, Co-Founder, FutureMed elucidates on the impact that trial and error has had on patients earlier, but in today's age adverse drug reactions is considered to be the fourth leading cause of death worldwide and has almost doubled in India in the last three years

time-read
3 minutos  |
February 2020